Literature DB >> 20229000

Electroencephalographic response following midazolam-induced general anesthesia: relationship to plasma and effect-site midazolam concentrations.

Wakako Miyake1, Yutaka Oda, Yuko Ikeda, Satoshi Hagihira, Hiroyoshi Iwaki, Akira Asada.   

Abstract

PURPOSE: To examine the relationships between effect-site concentrations and electroencephalographic parameters after the induction of general anesthesia with midazolam.
METHODS: Twenty-four patients with American Society of Anesthesiologists status I or II were randomly allocated to receive either an intravenous (i.v.) bolus of midazolam 0.2 mg kg(-1) (small-dose group, n = 12) or 0.3 mg kg(-1) (large-dose group, n = 12) for induction of general anesthesia in a double-blind experimental design. The bispectral index (BIS), 95% spectral edge frequency (SEF95), spectral power density, and plasma concentrations of midazolam were measured for 60 min following the induction of general anesthesia.
RESULTS: Plasma and simulated effect-site concentrations of midazolam were significantly higher in the large-dose group than in the small-dose group (P = 0.005 and <0.001, respectively). There was a correlation between the relative beta ratio and BIS (r (2) = 0.30, P < 0.001; n = 168); however, effect-site concentrations of midazolam showed no association with BIS, relative beta ratio, or SEF95 (r (2) = 0.07, 0.11 and 0.01, respectively; n = 168). The electroencephalographic spectral power density in the beta-band (>/=13 and <30 Hz) was significantly increased after induction and was significantly larger in the large-dose group than in the small-dose group (P = 0.009).
CONCLUSION: Following the induction of general anesthesia with i.v. midazolam 0.2 or 0.3 mg kg(-1), the BIS was positively correlated with the relative beta ratio. Despite a rapid decrease in the plasma and effect-site concentrations of midazolam, the average BIS remained >60 for 60 min after induction, reflecting an increased power of the electroencephalographic high-frequency band.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229000     DOI: 10.1007/s00540-010-0907-4

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  20 in total

1.  Electroencephalographic bicoherence is sensitive to noxious stimuli during isoflurane or sevoflurane anesthesia.

Authors:  Satoshi Hagihira; Masaki Takashina; Takahiko Mori; Hiroshi Ueyama; Takashi Mashimo
Journal:  Anesthesiology       Date:  2004-04       Impact factor: 7.892

2.  Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis.

Authors:  Yasunori Kaneshiro; Yutaka Oda; Kentaro Iwakiri; Toshiaki Masada; Hiroyoshi Iwaki; Yoshio Hirota; Kyoko Kondo; Kunio Takaoka
Journal:  Clin Pharmacol Ther       Date:  2006-10       Impact factor: 6.875

3.  Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.

Authors:  D J Greenblatt; B L Ehrenberg; J Gunderman; A Locniskar; J M Scavone; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1989-04       Impact factor: 6.875

4.  Comparison of midazolam and propofol in combination with alfentanil for total intravenous anesthesia.

Authors:  J Vuyk; P J Hennis; A G Burm; J W de Voogt; J Spierdijk
Journal:  Anesth Analg       Date:  1990-12       Impact factor: 5.108

5.  Biphasic EEG changes in relation to loss of consciousness during induction with thiopental, propofol, etomidate, midazolam or sevoflurane.

Authors:  K Kuizenga; J M Wierda; C J Kalkman
Journal:  Br J Anaesth       Date:  2001-03       Impact factor: 9.166

6.  Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.

Authors:  N Hamaoka; Y Oda; I Hase; K Mizutani; T Nakamoto; T Ishizaki; A Asada
Journal:  Clin Pharmacol Ther       Date:  1999-08       Impact factor: 6.875

7.  Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.

Authors:  S N de Wildt; M de Hoog; A A Vinks; E van der Giesen; J N van den Anker
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

8.  Anesthesia awareness and the bispectral index.

Authors:  Michael S Avidan; Lini Zhang; Beth A Burnside; Kevin J Finkel; Adam C Searleman; Jacqueline A Selvidge; Leif Saager; Michelle S Turner; Srikar Rao; Michael Bottros; Charles Hantler; Eric Jacobsohn; Alex S Evers
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

9.  Detection of awareness in surgical patients with EEG-based indices--bispectral index and patient state index.

Authors:  G Schneider; A W Gelb; B Schmeller; R Tschakert; E Kochs
Journal:  Br J Anaesth       Date:  2003-09       Impact factor: 9.166

10.  The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.

Authors:  Andra Ibrahim; Aziz Karim; Jennifer Feldman; Evan Kharasch
Journal:  Anesth Analg       Date:  2002-09       Impact factor: 5.108

View more
  8 in total

1.  Cross-conditional entropy and coherence analysis of pharmaco-EEG changes induced by alprazolam.

Authors:  J F Alonso; M A Mañanas; S Romero; M Rojas-Martínez; J Riba
Journal:  Psychopharmacology (Berl)       Date:  2011-11-30       Impact factor: 4.530

Review 2.  Distancing sedation in end-of-life care from physician-assisted suicide and euthanasia.

Authors:  Tze Ling Gwendoline Beatrice Soh; Lalit Kumar Radha Krishna; Shin Wei Sim; Alethea Chung Peng Yee
Journal:  Singapore Med J       Date:  2016-05       Impact factor: 1.858

3.  Use of bispectral index monitoring for a patient with hepatic encephalopathy requiring living donor liver transplantation: a case report.

Authors:  Hirobumi Okawa; Tomoko Ono; Eiji Hashiba; Toshihito Tsubo; Hironori Ishihara; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2010-12-03       Impact factor: 2.078

Review 4.  Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.

Authors:  Yasuhiro Morimoto
Journal:  Ther Clin Risk Manag       Date:  2022-02-02       Impact factor: 2.423

Review 5.  Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.

Authors:  Kyung Mi Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2022-01-20

Review 6.  Spectral edge frequency during general anaesthesia: A narrative literature review.

Authors:  Pether Jildenstål; Amanda Bäckström; Klara Hedman; Margareta Warrén-Stomberg
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

7.  A Response Surface Model Exploration of Dosing Strategies in Gastrointestinal Endoscopies Using Midazolam and Opioids.

Authors:  Jing-Yang Liou; Chien-Kun Ting; Ming-Chih Hou; Mei-Yung Tsou
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

8.  Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patients.

Authors:  Richard J Nies; Carsten Müller; Roman Pfister; Philipp S Binder; Nicole Nosseir; Felix S Nettersheim; Kathrin Kuhr; Martin H J Wiesen; Matthias Kochanek; Guido Michels
Journal:  J Intensive Care       Date:  2018-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.